Volume 82, Issue 7, Pages (October 2012)

Slides:

Advertisements

Similar presentations

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Advertisements

Management of IgA nephropathy: Evidence-based recommendations

Propofol-related green urine

Anemia management in chronic kidney disease

Volume 83, Issue 3, Pages (March 2013)

Stem cells for kidney repair: useful tool for acute renal failure?

C-reactive protein and dialysis access

Reassessment of the care of the patient with chronic kidney disease

Volume 80, Issue 10, Pages (November 2011)

C-reactive protein and dialysis access

Volume 77, Issue 1, Pages 6-8 (January 2010)

Haiyan Wang, Luxia Zhang, Jicheng Lv Kidney International

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Fu L. Luan, Diane E. Steffick,

Steven J. Chadban, Natalie D. Staplin Kidney International

Volume 66, Issue 3, Pages (September 2004)

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

The new role of calcimimetics as vasculotropic agents

Anti-glomerular basement membrane autoantibodies against different target antigens are associated with disease severity Juan Zhao, Zhao Cui, Rui Yang,

Volume 70, Issue 11, Pages (December 2006)

Renal risk scores: Progress and prospects

A novel classification for IgA nephropathy

Use of vitamin D in chronic kidney disease patients

Volume 87, Issue 2, Pages (February 2015)

Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.

Volume 71, Issue 4, Pages (February 2007)

Volume 70, Issue 12, Pages (December 2006)

Volume 67, Pages S48-S51 (January 2005)

Frank Eitner, Jürgen Floege Kidney International

Volume 76, Issue 5, Pages (September 2009)

Volume 80, Issue 1, Pages (July 2011)

Fructose intake as a risk factor for kidney stone disease

Response to ‘Hepcidin levels in patients with renal disease’

Volume 73, Issue 12, Pages (June 2008)

Volume 76, Issue 6, Pages (September 2009)

Capturing the in vivo molecular signature of the podocyte

Yijian Huang, Rebecca Zhang, Steven D. Culler, Nancy G. Kutner

Volume 71, Issue 11, Pages (June 2007)

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Volume 65, Issue 4, Pages (April 2004)

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

IgA nephropathy at two score and one

Volume 85, Issue 1, Pages (January 2014)

Counteracting progression of renal disease: A look into the future

Nephrology Crossword: Glomerulonephritis

Volume 74, Issue 5, Pages (September 2008)

Volume 69, Issue 8, Pages (April 2006)

Unilateral renal cystic disease

Volume 73, Issue 9, Pages (May 2008)

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients B. Bammens, P. Evenepoel, H. Keuleers,

Volume 74, Issue 9, Pages (November 2008)

Kathy E. Sietsema, Antonino Amato, Sharon G. Adler, Eric P. Brass

Volume 73, Issue 5, Pages (March 2008)

Volume 61, Issue 5, Pages (May 2002)

Volume 80, Issue 10, Pages (November 2011)

Treatment of the primary hyperoxalurias: A new chapter

Volume 64, Issue 4, Pages (October 2003)

Is complement a target for therapy in renal disease?

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

Membranous nephropathy: recent travels and new roads ahead

Volume 70, Issue 10, Pages (November 2006)

Volume 80, Issue 9, Pages (November 2011)

Prediction in idiopathic membranous nephropathy

Laura M. Krinsky, William J. Levine Kidney International

Volume 60, Issue 2, Pages (August 2001)

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Volume 82, Issue 7, Pages 790-796 (October 2012) The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression Na Zhao, Ping Hou, Jicheng Lv, Zina Moldoveanu, Yifu Li, Krzysztof Kiryluk, Ali G. Gharavi, Jan Novak, Hong Zhang Kidney International Volume 82, Issue 7, Pages 790-796 (October 2012) DOI: 10.1038/ki.2012.197 Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 1 Renal survival in IgA nephropathy (IgAN) patients with four quartile serum galactose-deficient IgA1 (Gd-IgA1) levels. The renal survival deteriorated by the quartile of serum Gd-IgA1 level. The time zero was kidney biopsy. The division between the four groups of patients was based on quartile of Gd-IgA1 level expressed as 236.5, 312.5, and 407.8U/ml. The renal survival at the first and third year in each group of patients was 100.0% and 96.9%; 100.0% and 91.8%; 100.0% and 92.2%; and 98.6% and 88.6%, respectively (log-rank test, P=0.004). Kidney International 2012 82, 790-796DOI: (10.1038/ki.2012.197) Copyright © 2012 International Society of Nephrology Terms and Conditions